Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AAC Clyde Space AAC Apr 9, 2021 2.72 +0.18   
 AAK AAK Apr 9, 2021 203.60 +0.15   
 ABB ABB Apr 9, 2021 272.80 +1.19   
 Abelco Investment Group ABIG Apr 9, 2021 0.11 0.00   
 Abera Bioscience ABERA Apr 9, 2021 11.90 0.00   
 ABG Sundal Collier Holding ABGO Apr 9, 2021 9.00 0.00   
 Abliva ABLI Apr 9, 2021 0.77 +1.32   
 Absolent Group ABSO Apr 9, 2021 378.00 -3.08   
 Absolicon ABSL Apr 9, 2021 142.00 +3.27   
 AcadeMedia ACAD Apr 9, 2021 87.20 -1.91   
 Acarix ACARIX Apr 9, 2021 1.43 -7.88   
 Acconeer ACCON Apr 9, 2021 36.55 -3.05   
 Acosense ACOS Apr 9, 2021 1.73 0.00   
 AcouSort ACOU Apr 9, 2021 25.90 +2.37   
 ACQ Bure ACQSPAC 0.00 0.00   
 Acrinova A ACRIA Apr 9, 2021 11.62 0.00   
 Acrinova B ACRIB Apr 9, 2021 13.60 0.00   
 ACROUD ACROUD Apr 9, 2021 3.89 +9.27   
 Actic Group ATIC Apr 9, 2021 17.35 +0.29   
 Active Biotech ACTI Apr 9, 2021 1.41 +0.57   
 AcuCort ACUC Apr 9, 2021 5.00 0.00   
 Adapteo ADAPT Apr 9, 2021 118.80 +0.34   
 AdderaCare ADDERA Apr 9, 2021 7.62 -0.78   
 AddLife B ALIFB Apr 9, 2021 186.00 -0.69   
 Addnode Group B ANODB Apr 9, 2021 271.50 +0.56   
 Addtech B ADDTB Apr 9, 2021 141.00 +1.44   
 ADDvise Group A ADDVA Apr 9, 2021 3.33 -9.02   
 ADDvise Group B ADDVB Apr 9, 2021 2.45 -1.61   
 Adevinta ADEO Apr 9, 2021 131.00 +1.95   
 Advenica ADVE Apr 9, 2021 5.14 -1.15   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK